Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Endocrinological Investigation
Published in: Journal of Endocrinological Investigation 9/2015

01-09-2015 | Review

Myocardial fat as a part of cardiac visceral adipose tissue: physiological and pathophysiological view

Authors: K. Selthofer-Relatić, I. Bošnjak

Published in: Journal of Endocrinological Investigation | Issue 9/2015

Login to get access

Abstract

Thoracic fat includes extra-pericardial (outside the visceral pericardium) and intra-pericardial (inside the visceral pericardium) adipose tissue. It is called ectopic adipose tissue although it is a normal anatomical structure. Intra-pericardial adipose tissue, which is predominantly composed of epicardial and pericoronary adipose tissue, has a significant role in cardiovascular system function. It provides metabolic-mechanical support to the heart and blood vessels in physiological conditions, while it represents metabolic-cardiovascular risk in case of qualitative and quantitative structural changes in the tissue: it correlates with coronary atherosclerotic disease, left ventricular mass, left atrium enlargement and atrial fibrillation presence. In the last decade there has been mounting evidence of fat cells presence in the myocardium of healthy (non-diseased) persons as well as in persons with both cardiovascular and non-cardiovascular diseases. Thus, it is necessary to clarify the incidence, aetiology, physiological role of fat cells in the myocardium, as well as the clinical significance of pathological fatty infiltration of the myocardium.
Literature
1.
Dey D, Nakazato R, Li D, Berman DS (2012) Epicardial and thoracic fat-noninvasive measurement and clinical implications. Cardiovasc Diagn Ther 2(2):85–93PubMedCentralPubMed
2.
Yun KH, Rhee SJ, Yoo NJ, Oh SK, Kim NH, Jeong JW et al (2009) Relationship between the echocardiographic epicardial adipose tissue thickness and serum adiponectin in patients with angina. J Cardiovac Ultrasond 17(4):121–126CrossRef
3.
Britton KA, Wang N, Palmisano J, Corsini E, Schlett CL, Hoffmann U et al (2013) Thoracic periaortic and visceral adipose tissue and their cross-sectional associations with measures of vascular function. Obesity (Silver Spring) 21(7):1496–1503CrossRef
4.
Bertaso AG, Bertol D, Duncan BB, Foppa M (2013) Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol 101(1):e18–e28PubMedCentralPubMed
5.
6.
Pananowitz L (2001) Fat infiltration in the heart. Heart 85:253
7.
Kimura F, Matsuo Y, Nakajima T, Nishikawa T, Kawamura S, Sannohe S et al (2010) Myocardial fat at cardiac imaging: how can we differentiate pathologic from physiologic fatty infiltration? Radiographics 30:1587–1602CrossRefPubMed
8.
Iozzo P (2011) Myocardial, perivascular and epicardial fat. Diab Care 34:S371–S379CrossRef
9.
Iozzo P, Lautamaki R, Borra R, Lehto HR, Bucci M, Viljanen A et al (2009) Contribution of glucose tolerance and sex to cardiac adiposity. J Clin Endocrinol Metab 94:4472–4482CrossRefPubMed
10.
Fitzgibbons TP, Cezch MP (2014) Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc 3:e000582PubMedCentralCrossRefPubMed
11.
Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G et al (2005) Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 29:251–255PubMed
12.
Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA et al (2009) Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 30:850–856PubMedCentralCrossRefPubMed
13.
Greenstein AS, Khavandi K, Wihers SB, Sonoyama K, Clancy O, Jeziorska M et al (2009) Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 119:1661–1670CrossRefPubMed
14.
Zhang H, Zhang C (2009) Regulation of microvascular function by adipose tissue in obesity and type 2 diabetes: evidence of adipose-vascular loop. Am J Biomed Sci 1:133–142PubMedCentralCrossRefPubMed
15.
Iacobellis G, Willens HJ (2009) Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 22:1311–1319CrossRefPubMed
16.
Fox CS, Gona P, Hoffmann U, Porter SA, Salton CJ, Massaro JM et al (2009) Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulaton 119:1586–1591CrossRef
17.
Natale F, Tedesco MA, Mocerino R, de Simone V, Di Marco GM, Aronne L et al (2009) Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 10:549–555CrossRefPubMed
18.
Britton KA, Pedley A, Massaro JM, Corsini EM, Murabito JM, Hoffmann U et al (2012) Prevalence, distribution, and ris factor correlates of high thoracic periaortic fat in the Framingham heart study. J Am Heart Assoc 1(6):e004200PubMedCentralCrossRefPubMed
19.
Marchington JM, Mattacks CA, Pond CM (1989) Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 94:225–232CrossRefPubMed
20.
Alexopoulos N, McLean DS, Janik M, Arepalli CD, Stillman AE, Raggi P (2010) Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 210:150–154CrossRefPubMed
21.
Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A et al (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88:5163–5168CrossRefPubMed
22.
23.
Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AF (2004) Ectopic fat storage, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 28:S58–S65CrossRefPubMed
24.
Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS et al (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcifications in a community-based sample: the Framingham Heart Study. Circulation 117:605–613CrossRefPubMed
25.
Savks HS, Fain JN, Bahouth SW, Ojha S, Frontini A, Budge H et al (2013) Adult epicardial fat exhibits beige features. J Clin Endocrinol Metab 98:E1448–E1455CrossRef
26.
Corradi D, Maestri R, Callegari S, Pastori P, Goldoni M, Luong TV et al (2004) The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 13:313–316CrossRefPubMed
27.
Venteclef N, Guglielmi V, Balse E, Gaborit B, Cotillard A, Atassi F et al (2013) Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. doi:10.​1093/​eurheartj/​eht099 PubMed
28.
Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G et al (2011) Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 57:1745–1751CrossRefPubMed
29.
Kim E, Choe YH, Han BK, Kim SM, Kim JS, Park SW et al (2007) Right ventricular fat infiltration in asymptomatic subjects: observation from ECG gated 16 slice multidetector CT. J Comput Assist Tomogr 31:22–28CrossRefPubMed
30.
Iacobellis G, Ribaudo MC, Zapaterrano A, Iannucci CV, Leonetti F (2004) Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 94:1084–1087CrossRefPubMed
31.
Khawaja T, Greer C, Chokshi A, Chavarria N, Thadani S, Jones M et al (2011) Epicardial fat volume in patients with left ventricular systolic dysfunction. Am J Cardiol 108:397–401CrossRefPubMed
32.
Enriga EC, Bakker W, Smulders YM, Serné EH, Yudkin JS, Stehouwer CDA (2007) Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 14:389–402CrossRef
33.
Vela D, Buja LM, Madjid M, Burke A, Naghavi M, Willerson JT, Casscells SW et al (2007) The role of periadventitial fat in atherosclerosis. Arch Pathol Lab Med 131:481–487PubMed
34.
Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM (2002) Periadventitial fat releases a vascular relaxing factor. FASEB J 16:1057–1063CrossRefPubMed
35.
Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS et al (2006) Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 5:1PubMedCentralCrossRefPubMed
36.
Yudkin JS, Eringa E, Stehouwer CD (2005) “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365:1817–1820CrossRefPubMed
37.
Gaborit B, Kober F, Jacquier A, Moro PJ, Flavian A, Quilici J et al (2012) Epicardial fat volume is associated with coronary microvascular response in healthy subjects: a pilot study. Obesity (Silver Spring) 20:1200–1205CrossRef
38.
39.
Demircelik MB, Yilmaz OC, Gurem OM, Selcoki Y, Atlar IA, Bozkurt A et al (2014) Epicardial adipose tissue and pericoronary fat thickness measured with 64-multidetector computed tomography: potential predictors of the severity of coronary artery disease. Clinics 69(6):388–392PubMedCentralCrossRefPubMed
40.
Basso C, Thiene G (2005) Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy: just a matter of fat? Cardiovasc Pathol 14:37–41CrossRefPubMed
41.
Tansey DK, Aly Z, Sheppard MN (2005) Fat in the right ventricle of the normal heart. Histopathology 46:98–104CrossRefPubMed
42.
43.
Litwin SE (2012) Normal weight obesity: is bigger really badder? Circ Cardiovasc Imaging 5:286–288CrossRefPubMed
44.
de la Grandmaison LG, Le Bihan C, Duringon M (2001) Assessment of right ventricular lipomatosis by histomorphometry in control adult autopsy cases. Int J Legal Med 115:105–108CrossRef
45.
Fontaine G, Fontaliran F, Zenati O, Guzman CE, Rigoulet J, Berthier JL et al (1999) Fat in the heart: a feature unique to the human species? Observational reflections on an unsolved problem. Acta Cardiol 54:189–194PubMed
46.
Goldfarb JW, Arnold S, Roth M, Han J (2007) T1-weighted magnetic resonance imaging shows fatty depositions after myocardial infarction. Magn Reson Med 57:828–834CrossRefPubMed
47.
Ahn SS, Kim YJ, Hur J, Lee HJ, Kim TH, Choe KO et al (2009) CT detection, of subendocardial fat in myocardial infarction. Am J Roentgenol 192:532–537CrossRef
48.
Minjie L, An J, Gang J, Shiliang J, Qiong L, Ning M et al (2012) Myocardial fat deposition in dilatated cardiomyopathy-assessment by using MR water-fat separation imaging. Heart 98:E249–E250
49.
Ichikawa Y, Kitagawa W, Chino S, Ishida M, Matsuoka K, Tanigawa T et al (2009) Adipose tissue detected by multislice computed tomography in patients after myocardial infarction. JACC Cardiovasc Imaging 2:548–555CrossRefPubMed
50.
Basso C, Ronco F, Marcus F, Abudureheman A, Rizzo S, Frigo AC et al (2008) Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J 29:2760–2771CrossRefPubMed
51.
Marcus F, McKenna WJ, Sherill D, Basso C, Bauce B, Bluemke DA et al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task force criteria. Circulation 121:1533–1541PubMedCentralCrossRefPubMed
52.
Kimura F, Sakai F, Sakomura Y, Fujimura M, Ueno E, Matsuda N et al (2002) Helical CT features of arrhythmogenic right ventricular cardiomyopathy. Radiographics 22:1111–1124CrossRefPubMed
53.
Heyer CM, Kagel T, Lemburg SP, Bauer TT, Nicolas V (2003) Lipomatous hypertrophy of the interatrial septum: a prospective study of incidence, imaging findings, and clinical symptoms. Chest 124:2068–2073CrossRefPubMed
54.
Araoz PA, Mulvagh SL, Tazelaar HD, Julsrud PR, Breen JF (2000) CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics 20:1303–1319CrossRefPubMed
55.
Shaaya EA, Hirshberg JS, Rabe OT, Thibert RL, Inglessis I, Sharma A et al (2013) Cardiac-fat containing lesions are common in tuberous sclerosis complex. AM J Med Genet A 161:1662–1665CrossRef
56.
Nishimura T, Yanagisawa A, Sakata H, Sakata K, Shimoyama K, Ishihara T et al (2001) Thallium-201 single photon emission computed tomography (SPECT) in patients with Duchenne’s progressive muscular dystrophy: a histopathologic correlation study. Jpn Circ J 65:99–105CrossRefPubMed
57.
Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT et al (2009) Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovasc Imaging 25:57–63PubMedCentralCrossRefPubMed
58.
Iacobellis G, Corradi D, Sharma AM (2005) Epicardial adipose tissue: anatomic, biomolecular and clinical relation to the heart. Nat Clin Pract Cardiovasc Med 2:536–543CrossRefPubMed
59.
Hartung H, Feldman B, Lovec H, Coulier F, Birnbaum D, Goldfarb M (1997) Murine FGF-12 and FGF-13: expression in embryonic nervous system, connective tissue and heart. Mech Dev 64(1–2):31–39CrossRefPubMed
60.
Van der Meer RW, Smit JW, Hammer S, Schär M, Bax JJ, Smit JW et al (2008) The ageing male heart: myocardial triglyceride contents as independent predictor of diastolic dysfunction. Eur Heart J 29:1516–1522CrossRefPubMed
61.
Lou BT, Jiang HG, Zhao YH, Chen XY (2010) Pathology of myocardial fatty infiltration: an autopsy report from 117 cases. Zhonghua Xin Guan Bing Za Zhi 38:350–353
62.
Malavazos AE, Di Leo G, Secchi F, Lupo EN, Dogliotti G, Coman C et al (2010) Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 105(12):1831–1835CrossRefPubMed
63.
Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM et al (2001) Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 280:H2726–H2731PubMed
64.
Su L, Siegel JE, Fishbein MC (2004) Adipose tissue in myocardial infarction. Cardiovasc Pathol 13:98–102CrossRefPubMed
65.
Sieber-Blum M (2004) Cardiac neural crest stem cells. Anat Rec A Discov Mol Cell Evol Biol 276:34–42CrossRefPubMed
66.
D’Amati G, di Gioia CRT, Giordano C, Gallo P (2000) Myocyte transdifferentiation. A possible pathogenic mechanism for arrhythmogenic right ventricular cardiomyopathy. Arch Pathol Lab Med 124:287–290PubMed
67.
Chellamuthu S, Smith AM, Thomas SM, Hill C, Brown PW, Al-Mohammad A (2014) Is cardiac MRI an effective test for arrhythmogenic right ventricular cardiomyopathy diagnosis? World J Cardiol 26(6):675–681CrossRef
68.
Feng Y, Wang Y, Cao N, Yang H, Wang Y (2012) Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope? Ann Palliat Med 1:65–77PubMedCentralPubMed
69.
Selthofer-Relatić K (2014) Cardiac visceral adiposity and right ventricle apex remodelling—locus minoris resistentiae. Med Hypo 82:404
70.
Selthofer-Relatić K, Rajc J, Belovari T, Bošnjak I, Dumenčić B (2014) Fatty infiltration of the right heart—histopathological human analysis. Cardiologia Croatica 9(9–10):444CrossRef
71.
Lazzarini V, Mentz RJ, Fiuzat M, Metra M, O’Connor CM (2013) Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail 15:717–723PubMedCentralCrossRefPubMed
72.
73.
Crendal E, Dutheil F, Naughton G, McDonald T, Obert P (2014) Increased myocardial dysfunction, dyssynchrony, and epicardial fat across the lifespan in healthy males. BMC Cardiovasc Disord 14:95PubMedCentralCrossRefPubMed
Metadata
Title
Myocardial fat as a part of cardiac visceral adipose tissue: physiological and pathophysiological view
Authors
K. Selthofer-Relatić
I. Bošnjak
Publication date
01-09-2015
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 9/2015
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-015-0258-y

Other articles of this Issue 9/2015

Journal of Endocrinological Investigation 9/2015 Go to the issue

Endocrinology and Art

The acromegalic voice of Tango: Don Edmundo Rivero

Original Article

Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy

Original Article

The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus

Original Article

Comparison of conventional l-thyroxine withdrawal and moderate hypothyroidism in preparation for whole-body 131-I scan and thyroglobulin testing

Original Article

Evaluation of function and structure of arterial wall in girls and young women with Turner syndrome

Original Article

Prediction of different ovarian responses using anti-Müllerian hormone following a long agonist treatment protocol for IVF
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits